Edap Tms (NASDAQ:EDAP) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP) in a research report issued on Friday. The firm set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Stock Up 0.9 %

NASDAQ:EDAP opened at $2.30 on Friday. Edap Tms has a 52 week low of $2.00 and a 52 week high of $8.50. The stock’s fifty day moving average is $2.27 and its two-hundred day moving average is $3.02. The stock has a market capitalization of $85.33 million, a price-to-earnings ratio of -3.54 and a beta of 0.36. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Thursday, November 7th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.03). The firm had revenue of $14.42 million for the quarter, compared to analyst estimates of $17.00 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. During the same period in the previous year, the company posted ($0.12) EPS. Research analysts anticipate that Edap Tms will post -0.6 EPS for the current year.

Hedge Funds Weigh In On Edap Tms

Several institutional investors have recently modified their holdings of EDAP. Redhawk Wealth Advisors Inc. purchased a new position in Edap Tms in the third quarter valued at $36,000. BNP Paribas Financial Markets boosted its stake in shares of Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares during the period. Orion Capital Management LLC boosted its stake in shares of Edap Tms by 10.4% in the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares during the period. Finally, Parkman Healthcare Partners LLC acquired a new position in shares of Edap Tms during the third quarter worth about $395,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.